Role of visfatin, insulin-like growth factor-I and insulin in fetal growth

Journal of Perinatal Medicine

Volumn 35, Issue 4, 2007, Pages 326-329

  Briana, Despina D ^a   Boutsikou, Maria ^a   Gourgiotis, Dimitrios ^a   Kontara, Louiza ^a   Baka, Stavroula ^a   Iacovidou, Nicoletta ^a   Hassiakos, Dimitrios ^a   Malamitsi Puchner, Ariadne ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Fetus; IGF I; Insulin; Intrauterine growth restriction; Neonate; Visfatin

Indexed keywords

INSULIN; SOMATOMEDIN C; VISFATIN;

ARTICLE; BIRTH WEIGHT; ENZYME IMMUNOASSAY; FETUS GROWTH; HUMAN; INFANT; NORMAL HUMAN; PERINATAL PERIOD; PRIORITY JOURNAL;

BIRTH WEIGHT; CYTOKINES; FEMALE; FETAL BLOOD; FETAL DEVELOPMENT; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; PREGNANCY;

EID: 34447128923     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2007.071     Document Type: Article

References (26)

1. Allan GJ, Flint DJ, Patel K. Insulin-like growth factor axis during embryonic development. Reproduction. 2001;122:31-9.
2. Baker J, Liu JP, Robertson EJ. A Efstratiadis: role of insulin-like growth factors in embryonic and postanatal growth. Cell. 1993;75:73-82.
3. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36:62-7.
4. Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005;54:2911-6.
5. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, et al. Elevated plasma level of visfatin/pre-B-cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006;91:295-9.
6. Christou H, Connors JM, Ziotopoulou M, Hatzidakis V, Papathanassoglou E, Ringer SA, et al. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab. 2001;86:935-8.
7. Dominici FP, Argentino DP, Munoz MC, Miquet JG, Sotelo AI, Turyn D. Influence of the crosstalk between growth hormone and insulin signaling on the modulation of insulin sensitivity. Growth Horm IGF Res. 2005;15:324-36.
8. Eriksson JG, Forsen T, Tuomilehto J, Jaddoe VW, Osmond C, Barker DJ. Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia. 2002;45:342-8.
9. Fant ME, Weisoly D. Insulin and insulin-like growth factors in human development: implications for the perinatal period. Semin Perinatol. 2001;25:426-35.
10. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426-30.
11. Gardosi J, Chang A, Kaylan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet. 1992;339:283-7.
12. Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol. 1995;6:168-74.
13. Gluckman PD, Harding JE. Fetal growth retardation: underlying endocrine mechanisms and postnatal consequences. Acta Paediatr. 1997;422:69-72.
14. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia. 2006;49:1909-14.
15. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 2006;91:1578-81.
16. Jensen RB, Chellakooty M, Vielwerth S, Vaag A, Larsen T, Greisen G, et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insulin-like growth factor-I play a role? Horm Res. 2003;60:136-48.
17. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995;16:3-34.
18. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol. 2005;185:R1-8.
19. Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond). 2006;110:605-9.
20. Mantzoros C, Petridou E, Alexe DM, Skalkidou A, Dessypris N, Papathoma E, et al. Serum adiponectin concentrations in relation to maternal and perinatal characteristics in newborns. Eur J Endocrinol. 2004;151:741-6.
21. Mostyn A, Keisler DH, Webb R, Stephenson T, Symonds MF. The role of leptin in the transition from fetus to neonate. Proc Nutr Soc. 2001;60:187-94.
22. Ogilvy-Stuart AL, Hands SJ, Adcock CJ, Holly JM, Matthews DR, Mohamed-Ali V, et al. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab. 1998;83:3550-7.
23. Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol. 2002;187:1051-8.
24. Randhawa R, Cohen P. The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab. 2005;86:84-90.
25. Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP. Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia. 1994;37:624-31.
26. Yang SW, Kim SY. The relationship of the levels of leptin, insulin-like growth factor-I and insulin in cord blood with birth size, ponderal index, and gender difference. J Pediatr Endocrinol Metab. 2000;13:289-96.